Search

Search Constraints

You searched for: Author/Creator Neisius, Andreas

Search Results

2. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022)

3. PD50-01 DURATION OF FOLLOW-UP AND TIMING OF DISCHARGE IN ADULT PATIENTS WITH UROLITHIASIS AFTER SURGICAL OR MEDICAL INTERVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS FROM THE EUROPEAN ASSOCIATION OF UROLOGY GUIDELINE PANEL ON UROLITHIASIS. (May 2022)

4. MP44-01 WHAT IS THE IDEAL FOLLOW UP AFTER KIDNEY STONE TREATMENT? A SYSTEMATIC REVIEW AND FOLLOW-UP ALGORITHM FROM THE EUROPEAN ASSOCIATION OF UROLOGY UROLITHIASIS PANEL. (May 2022)

5. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021)

6. Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines panel. Issue 5 (October 2020)

7. Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy. Issue 6 (November 2017)